Detalhe da pesquisa
1.
Methods for Including Adverse Events in Economic Evaluations: Suggestions for Improvement.
Value Health
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548180
2.
Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps.
Value Health
; 27(5): 623-632, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369282
3.
Consolidated Health Economic Evaluation Reporting Standards for Interventions that use Artificial Intelligence (CHEERS-AI).
Value Health
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795956
4.
A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report.
Value Health
; 26(8): 1137-1144, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37516531
5.
Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe.
J Asthma
; 60(1): 76-86, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35012410
6.
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations.
Int J Technol Assess Health Care
; 39(1): e24, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37092749
7.
Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations.
Value Health
; 25(5): 773-784, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35181207
8.
Capturing what matters: updating NICE methods guidance on measuring and valuing health.
Qual Life Res
; 31(7): 2167-2173, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35247152
9.
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom.
Int J Obes (Lond)
; 45(11): 2347-2357, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267326
10.
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.
Rheumatology (Oxford)
; 60(SI): SI37-SI50, 2021 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33725121
11.
Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations.
Value Health
; 23(11): 1409-1422, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33127010
12.
Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip Replacement: A Systematic Review and Network Meta-Analysis.
Value Health
; 22(8): 953-969, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31426937
13.
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis.
Value Health
; 21(2): 176-184, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29477399
14.
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis.
Value Health
; 20(10): 1279-1287, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241887
15.
Drug-related problems in cardiac children.
Minerva Pediatr
; 68(2): 89-95, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25034220
16.
NICE NG89 recommendations for extended pharmacological thromboprophylaxis - is it justified and is it cost effective: a rebuttal from the British Society for Haematology - response to Lester et al.
Br J Haematol
; 186(5): 788-789, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31148151
17.
A systematic review of economic evaluations of pharmacological treatments for active tuberculosis.
Front Public Health
; 12: 1201512, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689771
18.
Estimating the SF-6Dv1 Value Set for a Population-Based Sample in Lebanon.
Value Health Reg Issues
; 42: 1-10, 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340672
19.
Markov modeling for cost-effectiveness using federated health data network.
J Am Med Inform Assoc
; 31(5): 1093-1101, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38472144
20.
Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations.
Front Pharmacol
; 14: 1291164, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38035028